SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000819050-20-000231
Filing Date
2020-11-12
Accepted
2020-11-12 16:16:29
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbi-20200930.htm   iXBRL 10-Q 1303018
2 EX-31.1 a2020093010qex311.htm EX-31.1 10130
3 EX-31.2 a2020093010qex312.htm EX-31.2 9790
4 EX-32.1 a2020093010qex321.htm EX-32.1 8937
  Complete submission text file 0000819050-20-000231.txt   4990930

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20200930.xsd EX-101.SCH 38100
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20200930_cal.xml EX-101.CAL 56687
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20200930_def.xml EX-101.DEF 176266
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20200930_lab.xml EX-101.LAB 452757
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20200930_pre.xml EX-101.PRE 284514
10 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20200930_htm.xml XML 615074
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21088 | Film No.: 201306905
SIC: 2836 Biological Products, (No Diagnostic Substances)